This site is intended only for Australian Healthcare Professionals

Search

Menu

Close

Sign In or RegisterLog OutOur medicinesTherapy areasExplore contentExplore contentEventsVideosMaterialsLet’s connectLet's ConnectContact usAsk a questionPfizer Medical InformationStay connectedSuggest a topicPharmacy HubKnowledge Hub

Menu

Close

Summary of Product Characteristics

Adverse Event Reporting

COVID-19 vaccines are provided free of charge for all Australians.8*

*For individuals aged 6 months and older. Standard doctor or pharmacy fees may apply.

Your recommendation matters!

Recommending vaccination can impact a patient’s intent to get vaccinated against COVID-19. Keeping your eligible patients up-to-date with COVID-19 vaccination remains a key preventative measure to help protect those at risk of COVID-19 infection, severe disease, hospitalisation, and death.7,9,10

Discuss a COMIRNATY vaccine with your eligible patients to help provide protection against COVID-19.1
Available Resources Brochure COMIRNATY Formulations Guide This guide will provide a quick reference to dosing, dilution, and storage information. DownloadLoading

PP-CMR-AUS-0372 12/2024

Brochure COMIRNATY JN.1 Pre-Filled Syringe Fact Card Information for use of the pre-filled syringe. DownloadLoading

PP-CMR-AUS-0374 12/2024

Brochure COVID-19 Conversation Starters A handy guide for starting discussions about COVID-19 vaccination with your eligible patients. DownloadLoading

PP-CMR-AUS-0373 12/2024

Brochure Long COVID Learn more about Long COVID & COVID-19 vaccine safety. DownloadLoading

PP-CMR-AUS-0375 12/2024

Brochure COMIRNATY Co-administration information  Download this COMIRNATY brochure for information on co-administration of COVID-19 with other vaccines, such as the Flu vaccine. DownloadLoading

PP-CMR-AUS-0406. 05/25.

 Access Materials Here LoadingUseful Links Visit Pfizer Medical information


Access accurate and balanced clinical and scientific information Visit website LoadingHigh Risk Groups: COVID-19

Some people can get very sick from COVID-19. Learn about the different groups and the steps you can take to protect yourself.

 Visit websiteLoading National Centre of Immunisation Research and Surveillance Australia COVID-19 vaccination - summary for immunisation providers Visit website Loading COMIRNATY Product Information (PI) and Consumer Medicine Information (CMI) Access the PI and CMI of Comirnaty via the Therapeutic Goods Administration (TGA) website below Visit website Loading Australian Technical Advisory Group on Immunisation (ATAGI) - Clinical Advice Access ATAGI clinical advice and latest recommendations on COVID-19 vaccines below Visit website LoadingReferences:COMIRNATY Product Information.Merkley E, et al. Vaccine. 2022;40(13):2020–2027.Kutasi K, et al. Sci Rep. 2022;12:13293.Mathieu E, et al. Our World In Data. Coronavirus (COVID-19) Vaccinations. Available online at: https://ourworldindata.org/covid-vaccinations. Accessed 25 July 2025.Polack FP, et al. N Engl J Med. 2020;383(27):2603–2615.AusVaxSafety. Pfizer COVID-19 vaccine safety data – all participants. Available at: https://www.ausvaxsafety.org.au/pfizer-covid-19-vaccine-adult-formulation/pfizer-covid-19-vaccine-safety-data-all-participants. Accessed 27 July 2025.Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook – COVID-19. Available at: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/covid-19#recommendations. Accessed 27 August 2025. Australian Government Department of Health and Aged Care. COVID-19 vaccine advice and recommendations. Available at: https://www.health.gov.au/our-work/covid-19-vaccines/getting-your-vaccination. Accessed 14 October 2025. CDC. Report of Health Care Provider Recommendation for COVID-19 Vaccination Among Adults, by Recipient COVID-19 Vaccination Status and Attitudes — United States, April–September 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7050a1.htm?s_cid=mm7050a1_w. Accessed 3 October 2025.CDC. Talking with patients about COVID-19 vaccination. Updated November 3, 2021. https://www.cdc.gov/vaccines/covid-19/hcp/engaging-patients.html. Accessed 3 October 2025.

Before prescribing, please review Product Information available here.

▼This vaccine is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at: http://www.tga.gov.au/safety/reporting-problems

PBS Information: COMIRNATY is not listed on the PBS and is not listed on the National Immunisation Program (NIP). 

COMIRNATY® is a registered trademark of BioNTech SE. used under licence ©2025. Pfizer Australia Pty Ltd. Sydney Australia. All rights reserved. 

PP-CMR-AUS-0459 11/25
PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about Pfizer medicines and vaccines.

Sign inRegisterAccountSign Out

The site is intended for Australian healthcare professionals.

 

©2026 Pfizer Australia Pty Ltd. Sydney, Australia. All rights reserved.

 

 

PP-UNP-AUS-0551 11/25.

You are now leaving Pfizer
You are leaving PfizerPro.
You may be directed to a third-party website.
Please note third-party websites are not controlled by Pfizer or subject to our privacy policy.
PP-UNP-AUS-0551 12/23.